Somatic mutations in recognized cancer genes, including tumor suppressor genes such as TSC2 and VHL, were discovered, as well as transcriptional activation of carcinogenic pathways including IGF-1, ERK/MAPK, PI3K/AKT, and TGFβ. This evidence concerns the gene TGFB1 and neoplasm.